Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies.
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2024
2024
Historique:
received:
21
02
2024
revised:
15
05
2024
accepted:
21
06
2024
medline:
19
8
2024
pubmed:
19
8
2024
entrez:
19
8
2024
Statut:
epublish
Résumé
Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet-rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new processes and methods of optimization. However, not enough consideration is being given to modify the molecular components of PRP to generate more effective formulations with the aim of improving PRP treatments. Therefore, this review covers different novel PRP-obtaining methods that attempt to modify the molecular composition of the plasma.
Identifiants
pubmed: 39157212
doi: 10.1155/2024/6444120
pmc: PMC11329313
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
6444120Informations de copyright
Copyright © 2024 Jon Mercader-Ruiz et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.